Identifying Intestinal Metaplasia at the Squamocolumnar Junction by Using Optical Coherence Tomography
Overview
Pharmacology
Radiology
Authors
Affiliations
Background: Optical coherence tomography (OCT) is an optical imaging method that produces high-resolution cross-sectional images of the esophagus. The accuracy of OCT for differentiating tissue types at the squamocolumnar junction (SCJ) has not been established.
Objective: The purpose of this study was to identify and validate OCT image criteria for distinguishing metaplastic from nonmetaplastic tissue at the SCJ.
Design: A total of 196 biopsy-correlated OCT images of the SCJ were acquired from 113 patients undergoing upper endoscopy. A pathologist blinded to the OCT results reviewed each pathology specimen and determined the presence of the following histopathology: gastric cardia, squamous mucosa, pancreatic metaplasia, and intestinal metaplasia. An algorithm for diagnosing specialized intestinal metaplasia (SIM) was created by reviewing a training set of 40 biopsy-correlated OCT images. Two blinded investigators prospectively tested the algorithm on a validation set of 123 images.
Results: OCT images of squamous mucosa were characterized by a layered appearance without epithelial glands; gastric cardia, by vertical pit and gland structure, a well-defined epithelial surface reflectivity, and relatively poor image penetration; and SIM by an irregular architecture and good image penetration. The OCT criteria were 85% sensitive and 95% specific for SIM when applied retrospectively to the training set. When applied to the validation set, the algorithm was 81% sensitive for both OCT readers and 66% and 57% specific for diagnosing SIM. The interobserver agreement was good (kappa = 0.53).
Conclusions: OCT imaging can identify SIM at the SCJ with an accuracy similar to that of endoscopy.
Vaselli M, Gabriels R, Schmidt I, Sterkenburg A, Kats-Ugurlu G, Nagengast W Biomed Opt Express. 2024; 15(10):5706-5722.
PMID: 39421768 PMC: 11482167. DOI: 10.1364/BOE.537828.
Attendu X, Bloemen P, Kind N, Faber D, de Bruin D, Boudoux C J Biomed Opt. 2024; 29(9):096003.
PMID: 39301278 PMC: 11412323. DOI: 10.1117/1.JBO.29.9.096003.
Park H, Li D, Liang R, Adrales G, Li X BME Front. 2024; 5:0041.
PMID: 38577399 PMC: 10993155. DOI: 10.34133/bmef.0041.
Advances in Screening for Barrett Esophagus and Esophageal Adenocarcinoma.
Vantanasiri K, Kamboj A, Kisiel J, Iyer P Mayo Clin Proc. 2024; 99(3):459-473.
PMID: 38276943 PMC: 10922282. DOI: 10.1016/j.mayocp.2023.07.014.
Bouma B, de Boer J, Huang D, Jang I, Yonetsu T, Leggett C Nat Rev Methods Primers. 2023; 2.
PMID: 36751306 PMC: 9901537. DOI: 10.1038/s43586-022-00162-2.